Stock listing

Alk-abello A/s Class B

Selected listing: ALKB · VIE · EUR · AT

Alk-abello A/s Class B (Vienna:ALKB), Health Technology. Latest release May 4, 2026: ALK upgrades its full-year outlook.

ALKB:VIEEURATUpdated October 2, 2026

Ticker: Vienna:ALKB
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Vienna
Currency: EUR

About Alk-abello A/s Class B

Alk-abello A/s Class B is a publicly traded company in Denmark, listed under the ticker ALK B. Alk-abello specializes in allergy immunotherapy products and solutions, contributing to advancements in allergy treatment and management.

Latest news from Alk-abello A/s Class B

ALK upgrades its full-year outlook

May 4, 2026

Invitation to the presentation of ALK’s first quarter 2026 results on Tuesday, 5 May 2026

April 28, 2026

Annual General Meeting in ALK-Abelló A/S held on 16 March 2026

March 16, 2026

New data reveals 9 in 10 people prefer EURneffy, a needle-free nasal adrenaline spray, over auto-injectors

March 4, 2026

Annual General Meeting in ALK-Abelló A/S on 16 March 2026

February 20, 2026

All Alk-abello A/s Class B news →

Events

Replays

Alk-Abello As B Shs New (AKBLF) Q2 2026 Earnings Call
Thu, Aug 20, 2026 · 07:30 AM ET
Watch
Alk-Abello As B Shs New (AKBLF) Q1 2026 Earnings Call
Mon, May 04, 2026 · 05:00 AM ET
Watch
Alk-Abello As B Shs New (AKBLF) Q4 2025 Earnings Call
Fri, Feb 20, 2026 · 05:00 AM ET
Watch

Research Alk-abello A/s Class B

Alk-abello A/s Class B company profile

View the public company page for Alk-abello A/s Class B on 6ix.

Alk-abello A/s Class B news

Read company news and market updates connected to Alk-abello A/s Class B.

Alk-abello A/s Class B investor events

Find investor webinars, events, and replay context for Alk-abello A/s Class B.